Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
NCT04938609 · ACTIVE NOT RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Providence Health Services. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Providence Health Services.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Providence Health Services currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Providence Health Services conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.